A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/13/2001	US6316497 For suppressing cell proliferation and neovascularization
11/13/2001	US6316483 Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions
11/13/2001	US6316481 Pharmaceutical composition containing proton pump inhibitors
11/13/2001	US6316460 Containing a heptenoic acid derivative and a tribasic phosphate salt as a stabilizer; hmg-coa reductase inhibitor
11/13/2001	US6316453 Aqueous pharmaceutical composition
11/13/2001	US6316433 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/13/2001	US6316424 Sulfated phosphatidylinositols, their preparation and use of the same
11/13/2001	US6316422 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/13/2001	US6316421 Pentaerythritol lipid derivatives and nuleic-acid complexes
11/13/2001	US6316417 Parenteral formulations comprising carbamazepine or its derivatives
11/13/2001	US6316260 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
11/13/2001	US6316259 Antisense inhibition of glycogen synthase kinase 3 alpha expression
11/13/2001	US6316153 Free-form fabricaton using multi-photon excitation
11/13/2001	US6316031 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
11/13/2001	US6316030 Use of nanoscale sterols and sterol esters
11/13/2001	US6316029 Rapidly disintegrating solid oral dosage form
11/13/2001	US6316028 Time-release agents
11/13/2001	US6316027 Fast-dissolving dosage forms for dopamine agonists
11/13/2001	US6316026 Punching a tablet out of pharmaceutical formulation containing one or more than one medicinal agents and one or more than one water-soluble saccharides without using water-soluble binding agent under pressure shaping tablet by moisturizing, drying
11/13/2001	US6316025 Absorption upon digestion
11/13/2001	US6316024 Therapeutic liposome composition and method of preparation
11/13/2001	US6316023 TTS containing an antioxidant
11/13/2001	US6316022 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
11/13/2001	US6316021 Extensible mask including an adhesive matrix that can be stretched at least in the wet state
11/13/2001	US6316020 For therapy of gastric acid related diseases in mammals
11/13/2001	US6316019 For topical drug delivery
11/13/2001	US6316011 End modified thermal responsive hydrogels
11/13/2001	US6316008 Combination of zinc ions and vitamin C and method of making
11/13/2001	US6316001 Method for treatment of psoriasis
11/13/2001	US6315994 Providing pancreatic tissue comprising islet cells and acinar cells; encapsulating in matrix comprising gelatin and polar amino acid selected from arginine, lysine, histidine, glutamic acid, and aspartic acid; introducing transplant into host
11/13/2001	US6315987 Polymeric delivery and release systems for oral care actives
11/13/2001	US6315985 C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
11/13/2001	US6315984 For administration of large-molecule pharmaceuticals, e.g. peptidic drugs, vaccines and hormones
11/13/2001	US6315983 Process for the production of powdered pulmonary surfactant preparations
11/13/2001	US6315981 Used for obtaining image of an internal region of humans
11/13/2001	US6315907 Bringing a body fluid containing toxic shock syndrome toxin-1 into contact with an absorbent comprising a water-insoluble carrier and compound immobilized on carrier
11/13/2001	US6315854 Transdermal therapeutic plaster
11/13/2001	US6315756 Tumescent solution
11/13/2001	US6315173 Valve for aerosol container
11/13/2001	US6314956 Treating lung defects associated hypoxemia or smooth muscle constriction; administer ethyl nitrite to human and monitor
11/11/2001	CA2347301A1 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
11/09/2001	CA2345498A1 Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products
11/08/2001	WO2001084565A2 Method and apparatus for manufacture of magnetizable microparticles
11/08/2001	WO2001083704A1 Spray-dried microbial cells
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083594A1 Method for preparing microsphere
11/08/2001	WO2001083564A1 Amphiphilic macrocyclic derivatives and their analogues
11/08/2001	WO2001083521A2 Reductive alkylation process on glycopeptides
11/08/2001	WO2001083520A2 Polyacid glycopeptide derivatives
11/08/2001	WO2001083513A2 Antisense modulation of inhibitor of dna binding-1 expression
11/08/2001	WO2001083508A1 Antisense modulation of zinc finger protein-217 expression
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001083398A2 System for the release of active ingredients
11/08/2001	WO2001083385A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
11/08/2001	WO2001083099A1 Method and facility for producing micromembrane capsules
11/08/2001	WO2001083093A1 Process and device for producing liquid dosage formulations
11/08/2001	WO2001083020A1 Antineoplastic platinum therapeutic method and composition
11/08/2001	WO2001082984A2 Low ionic strength ophthalmic compositions
11/08/2001	WO2001082981A1 A medicinal aerosol formulation
11/08/2001	WO2001082980A1 A medicinal aerosol formulation
11/08/2001	WO2001082971A2 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	WO2001082970A1 Mixtures of triblock polyesterpolyethylene glycol copolymers
11/08/2001	WO2001082966A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	WO2001082956A1 Pharmaceutical composition
11/08/2001	WO2001082950A1 Pernasally absorbable insulin preparations
11/08/2001	WO2001082943A2 Subcutaneous administration of coagulation factor vii
11/08/2001	WO2001082941A1 Composition for treatment of b-type hepatitis and liver cirrhosis
11/08/2001	WO2001082931A1 (+) naloxone and epinephrine combination therapy
11/08/2001	WO2001082915A2 Trans-clitoral administration of therapy
11/08/2001	WO2001082910A2 Combination of progesterone and mifepristone for cancer therapy
11/08/2001	WO2001082906A1 Powders for use in a dry powder inhaler
11/08/2001	WO2001082905A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir
11/08/2001	WO2001082904A1 A core formulation
11/08/2001	WO2001082903A1 Enteric coated formulation of bisphosphonic acid compounds and associated therapeutic methods
11/08/2001	WO2001082902A1 Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
11/08/2001	WO2001082901A1 New antibodies to biological membranes
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082899A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
11/08/2001	WO2001082898A1 Improved lactational
11/08/2001	WO2001082897A2 Liposome drug delivery
11/08/2001	WO2001082895A2 Guaifenesin sustained release formulation and tablets
11/08/2001	WO2001082894A2 Directly compressed solid dosage particles
11/08/2001	WO2001082893A1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
11/08/2001	WO2001082892A2 Liposomes containing active substances
11/08/2001	WO2001082890A1 Eutectic mixtures in cosmetic compositions
11/08/2001	WO2001082886A1 Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
11/08/2001	WO2001082875A2 A core formulation
11/08/2001	WO2001082874A2 A medicinal aerosol formulation
11/08/2001	WO2001082873A2 A medicinal aerosol formulation
11/08/2001	WO2001082872A2 A medicinal aerosol formulation
11/08/2001	WO2001082868A2 A medicinal aerosol formulation
11/08/2001	WO2001082867A2 A core formulation
11/08/2001	WO2001082866A2 Cosmetic compositions containing film forming polymers plasticized with esters of malic acid
11/08/2001	WO2001082794A2 Fiber optic probe placement guide
11/08/2001	WO2001082702A1 Iodine-propylene glycol teat dip
11/08/2001	WO2001060349A3 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.
11/08/2001	WO2001045789A3 Ingestible device for the release of substances at distinct locations in the alimentary canal
11/08/2001	WO2001041776A3 Use of honey in medical dressings
11/08/2001	WO2001041760A3 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/08/2001	WO2001034617A3 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

1 ... 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 ... 2991